Avalo Therapeutics, Inc. operates as a clinical-stage precision medicine company. The Company discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. Avalo Therapeutics serves customers worldwide.
ncG1vNJzZmivp6x7o7jOqKSbnaKce6S7zGiorqekmnyCorORcY6L